Jenny Crowe

1.2k citations

30 papers · 973 indexed · h-index 19

Impact in

Parasitology top 5%
- Parasites and Host Interactions
Immunology top 10%
- Immune Cell Function and Interaction

Papers in

Aging 2
Immunology 13
- Immunodeficiency and Autoimmune Disorders 3
- Immunotherapy and Immune Responses 3
- Complement system in diseases 3

Co-authors: J. David Barry K Vickerman Jonathan H. Ellis William Harnett C. A. Ross A.G. Luckins Charles Cox Felicity E. Lumb
Journals: Scientific Reports (3 papers)Parasitology (3 papers)The Journal of Immunology (3 papers)Nature Communications (2 papers)Frontiers in Immunology (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Jenny Crowe

30 papers receiving 944 citations

Peers

Countries citing papers authored by Jenny Crowe

Since Specialization

Citations

This map shows the geographic impact of Jenny Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Crowe more than expected).

Fields of papers citing papers by Jenny Crowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Crowe. The network helps show where Jenny Crowe may publish in the future.

Co-authors

The 25 scholars most cited alongside Jenny Crowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jenny Crowe Line = papers co-authored together Jenny Crowe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing Frontiers in Immunology ·Margaret M. Harnett, James Doonan, Felicity E. Lumb, Jenny Crowe, C. Zimmermann-Nielsen, T Mohan Reddy, Sheng-Fen Fang, Trishkina Et, Colin J. Suckling, Colin Selman, William Harnett	2022	7
2	Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease Scientific Reports ·Kevin J. Roberts, Chuang Zhang, Lucas Watkins, Yuanlan Wang, Luana Maggiore, DICVP Lauren R. Eichstadt Forsythe, Simon Clare, Katherine Harcourt, Thomas T. MacDonald, Keith P. Ray, Anna Vossenkämper, Michael R. West, Jenny Crowe	2021	23
3	The parasitic worm product ES-62 promotes health- and life-span in a high calorie diet-accelerated mouse model of ageing PLoS Pathogens ·Jenny Crowe, Felicity E. Lumb, James Doonan, 浩之井澤, Anuradha Tarafdar, Miguel A. Pineda, Kulket Tohtubtiang, 仁知高村, Paul A. Hoskisson, Simon A. Babayan, Colin Selman, William Harnett, Margaret M. Harnett	2020	23
4	Challenging immunodominance of influenza-specific CD8+ T cell responses restricted by the risk-associated HLA-A68:01 allomorph Nature Communications* ·Carolien E. van de Sandt, E. Bridie Clemens, Emma J. Grant, Louise C. Rowntree, Sneha Sant, Hanim Halim, Jenny Crowe, Allen Cheng, Tom Kotsimbos, Michael J. Richards, Adrian Miller, Steven Y. C. Tong, Jamie Rossjohn, Thi H. O. Nguyen, Stéphanie Gras, Weisan Chen, Katherine Kedzierska	2019	19
5	The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis Nature Communications ·James Doonan, Anuradha Tarafdar, Miguel A. Pineda, Felicity E. Lumb, Jenny Crowe, Agnes Wemme, Paul A. Hoskisson, Margaret M. Harnett, William Harnett	2019	50
6	Synthetic small molecule analogues of the immunomodulatory Acanthocheilonema viteae product ES-62 promote metabolic homeostasis during obesity in a mouse model Molecular and Biochemical Parasitology ·Felicity E. Lumb, Jenny Crowe, James Doonan, Colin J. Suckling, Colin Selman, Margaret M. Harnett, William Harnett	2019	9
7	Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients Scientific Reports ·K.S. Surnina, Kevin J. Roberts, Lucas Watkins, Luana Maggiore, Chuang Zhang, Keith P. Ray, Jill Reckless, Valino Perez Arturo Jose, Peter M. Irving, Thomas T. MacDonald, Anna Vossenkämper, Michael R. West, Gareth Parkes, Jenny Crowe	2019	28
8	Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease Scientific Reports ·Jenny Crowe, Kevin J. Roberts, Lucas Watkins, Luana Maggiore, Chuang Zhang, Simon Clare, Katherine Harcourt, Jill Reckless, Thomas T. MacDonald, Keith P. Ray, Anna Vossenkämper, Michael R. West	2018	48
9	Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis Frontiers in Immunology ·James Doonan, Felicity E. Lumb, Miguel A. Pineda, Anuradha Tarafdar, Jenny Crowe, Agnes Wemme, Colin J. Suckling, Margaret M. Harnett, William Harnett	2018	30
10	Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeys Drug Development and Industrial Pharmacy ·Jenny Crowe, Kevin J. Roberts, Lucas Watkins, Luana Maggiore, Chuang Zhang, Keith P. Ray, Eleonora Venneri, John -Marc Comperat, O. santao, T. M. Beloklokova, Álvaro Alberto López-Lambraño, Michael R. West	2018	34
11	Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression Annals of the Rheumatic Diseases ·Ewan A. Ross, Amy J. Naylor, John D. O’Neil, T Crowley, Michael Ridley, Jenny Crowe, Timothy Smallie, 進保星野, Jason D. Turner, Lucy V. Norling, Salina Dominguez, Harris Perlman, Nicole M. Verrills, George Kollias, Michael P. Vitek, Andrew Filer, Christopher D. Buckley, Jonathan L. E. Dean, Andrew R. Clark	2016	62
12	Targeting human Ep‐CAM in transgenic mice by anti‐idiotype and antigen based vaccines International Journal of Cancer ·Szilvia Mosolits, Fiona Campbell, Sergey V. Litvinov, Jan Fagerberg, Jenny Crowe, Håkan Mellstedt, Jonathan H. Ellis	2004	5
13	A lack of evidence for down-modulation of CD3ζ expression in colorectal carcinoma and pregnancy using multiple detection methods Clinical & Experimental Immunology ·隆弘鈴木, M.H.J. Wolbers, Jenny Crowe, Victoria Trow, Angus Dalgleish, R. J. Leicester, Caroline Finlayson, W. F. A. Miles, Paul Life	1999	6
14	Interactions of CD80 and CD86 with CD28 and CTLA4 The Journal of Immunology ·Jonathan H. Ellis, Lauren M. Catalano, Muhibur Rahman, Claire Linge, Jenny Crowe	1996	67
15	Detection of Rare Allelic Variants of the Interferon-α ₂ Gene in Human Genomic DNA Journal of Interferon & Cytokine Research ·Dirk R. Gewert, Nigel A. Sharp, Yuan Qing-l, Helen Cooper, R. Bonin, IR Costa, Mark Thursz, Jenny Crowe	1995	8
16	Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma The Journal of Immunology ·Jonathan H. Ellis, Yuan Qing-l, Andrew Tutt, Christine Hale, Andrew Lewis, M J Glennie, G T Stevenson, Jenny Crowe	1995	66
17	Interferon (IFN)- 2 Genotype Analysis of Chinese Chronic Hepatitis B Patients Undergoing Recombinant IFN- 2a Therapy The Journal of Infectious Diseases ·Jenny Crowe, Dirk R. Gewert, Yuan Qing-l, Andrew Lewis, Martin Sims, Sarah L. Davies, Caroline Salom, James B. Wood, Howard C. Thomas, Mark Thursz, Anna S. Lok	1994	13
18	A humanized CD18 antibody can block function without cell destruction. The Journal of Immunology ·Martin Sims, J F Silva, Xiaoming Ma, Wendy C. Rowan, M. Lockyer, Hidayatul Jannah, Zhenxuan Liu, G Hale, Herman Waldmann, Jenny Crowe	1993	8
19	Analysis of trypanosome variable antigen types in cultures of metacyclic and mammalian forms of Trypanosoma congolense Parasitology ·A.G. Luckins, I. A. Frame, Nella Velicogna, Jenny Crowe, C. A. Ross	1986	16
20	Neutralization of individual variable antigen types in metacyclic populations ofTrypanosoma bruceidoes not prevent their subsequent expression in mice Parasitology ·J. David Barry, Jenny Crowe, K Vickerman	1985	19

About Jenny Crowe

Jenny Crowe is a scholar working on Aging, Immunology, Parasitology, Gastroenterology and Epidemiology, having authored 30 papers that have together received 973 indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (7 papers), Trypanosoma species research and implications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Inflammatory Bowel Disease (4 papers), Parasites and Host Interactions (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Immunotherapy and Immune Responses (3 papers) and Complement system in diseases (3 papers). The work is most often cited by research in Parasitology (167 citations), Immunology (265 citations), Epidemiology (405 citations), Public Health, Environmental and Occupational Health (270 citations) and Insect Science (90 citations). Jenny Crowe has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include J. David Barry, K Vickerman, Jonathan H. Ellis, William Harnett, C. A. Ross, A.G. Luckins, Charles Cox, Felicity E. Lumb, Margaret M. Harnett and James Doonan. Their work appears in journals such as Scientific Reports, Parasitology, The Journal of Immunology, Nature Communications and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact